Upstream Processing Featured Articles

  1. Seminars, Technology Highlight CYTO 2013 Offerings From Beckman Coulter Life Sciences 5/16/2013

    Presenting two seminars and seven poster sessions, Beckman Coulter Life Sciences will have a prominent role when CYTO 2013 convenes at the San Diego Convention Center May 18-22, 2013.

  2. Comparing Proteins At A Glance: Berkeley Lab Researchers Unveil Technique For Easy Comparisons Of Proteins in Solution 4/30/2013

    A revolutionary X-ray analytical technique that enables researchers at a glance to identify structural similarities and differences between multiple proteins under a variety of conditions has been developed by researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab).

  3. Suppressing Protein May Stem Alzheimer's Disease Process 4/25/2013

    Scientists funded by the National Institutes of Health have discovered a potential strategy for developing treatments to stem the disease process in Alzheimer’s disease.

  4. DSM And DecImmune Therapeutics Sign Agreement To Develop N2 Pathway Blocking Antibody 4/22/2013

    DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced recently that it has signed an agreement with venture capital funded DecImmune Therapeutics of Cambridge, Massachusetts, USA.

  5. Finesse Solutions And ATMI Sign Distribution Agreement For Turnkey Bioreactor Systems 4/16/2013

    Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announced the signing of a Distribution Agreement with ATMI, Inc., a global technology company and a leader in single-use process solutions.

  6. Antibody Evolution Could Guide HIV Vaccine Development 4/4/2013

    Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis from Los Alamos National Laboratory, has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.

  7. Endress+Hauser Introduces OUSBT66 Cell Density Sensor 4/1/2013

    Endress+Hauser introduces the OUSBT66 sensor for cell density measurement. Using near-Infrared (NIR) light absorbance technology, the OUSBT66 is a non-intrusive, hygienic sensor that is ideal for real time, in-situ cell production optimization in life science processes, fermentation biomass measurement and algae growth monitoring for biofuel production.

  8. Thermo Fisher Scientific Forms Technology Alliance Partnership With The University Of Birmingham, UK 3/28/2013

    Thermo Fisher Scientific Inc., the world leader in serving science, has entered into a Technology Alliance Partner agreement with scientists at the University of Birmingham, UK, establishing a collaboration to accelerate research in high-resolution accurate mass (HRAM) and triple quadrupole liquid chromatography-mass spectrometry (LC-MS) for life science applications.

  9. Theraclone Sciences Secures $14M In Additional Financing 3/25/2013

    Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, recently announced a $14M financing. $8M in equity is committed from existing investors ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, Amgen Ventures, Versant Ventures and Zenyaku Kogyo in a Series B Extension, bringing the total round to $50M.

  10. Waters And Dow Announce Major Breakthrough In Advanced Polymer Analysis At Pittcon 3/18/2013

    Waters Corporation recently unveiled several important new technologies at the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, commonly known as Pittcon, the annual premier conference and exposition on laboratory science.